This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive (Unicirc003)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Peter Millard, Simunye Primary Health Care
ClinicalTrials.gov Identifier:
NCT02091726
First received: March 14, 2014
Last updated: November 16, 2015
Last verified: November 2015
Results First Received: December 1, 2014  
Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment;   Masking: Open Label;   Primary Purpose: Prevention
Condition: Male Circumcision
Intervention: Procedure: Unicirc instrument plus cyanoacrylate tissue adhesive

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations

Three generalist physicians (GPs) performed the circumcisions in individual consultation rooms in their own primary health care clinic.

The study took place between January 20 and July 4, 2014.


Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
  Description
Unicirc With Tissue Adhesive

Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate

Unicirc instrument plus cyanoacrylate tissue adhesive: Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive


Participant Flow:   Overall Study
    Unicirc With Tissue Adhesive
STARTED   110 
1 Week Followup   110 
4 Week Followup   104 
COMPLETED   104 
NOT COMPLETED   6 
Lost to Follow-up                6 



  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
Volunteers

Reporting Groups
  Description
Unicirc With Tissue Adhesive

Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate

Unicirc instrument plus cyanoacrylate tissue adhesive: Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive


Baseline Measures
   Unicirc With Tissue Adhesive 
Overall Participants Analyzed 
[Units: Participants]
 110 
Age 
[Units: Participants]
 
<=18 years   0 
Between 18 and 65 years   110 
>=65 years   0 
Gender 
[Units: Participants]
 
Female   0 
Male   110 
Region of Enrollment 
[Units: Participants]
 
South Africa   110 


  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Time for Procedure   [ Time Frame: 1 hour ]

2.  Secondary:   Completely Healed at 4 Weeks   [ Time Frame: 4 weeks ]

3.  Secondary:   Wound Separation   [ Time Frame: 4 weeks ]

4.  Secondary:   Cosmetic Result Excellent   [ Time Frame: 4 weeks ]

5.  Secondary:   Participant Fully Satisfied and Would Recommend to Friends and Family   [ Time Frame: 4 weeks ]


  Serious Adverse Events


  Other Adverse Events


  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.


  More Information
  Hide More Information

Certain Agreements:  
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.


Results Point of Contact:  
Name/Title: Peter S. Millard, MD, PhD
Organization: University of New England
phone: 2072992131
e-mail: pmillard@mac.com


Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Peter Millard, Simunye Primary Health Care
ClinicalTrials.gov Identifier: NCT02091726     History of Changes
Other Study ID Numbers: Unicirc 003
Study First Received: March 14, 2014
Results First Received: December 1, 2014
Last Updated: November 16, 2015